MARKETSStocks End Down After Wall Street Worries Rate Cut Won't Be EnoughBy Joseph WoelfelMar 3, 2020 4:14 PM EST
PRESS RELEASESQIAGEN Shareholders Approve All Agenda Items Related To Acquisition By Thermo Fisher Scientific At Annual General MeetingBy Business WireJun 30, 2020 1:55 PM EDT
PRESS RELEASESQIAGEN Announces Plans To Release Preliminary Q2 2020 ResultsBy Business WireJun 22, 2020 4:05 PM EDT
PRESS RELEASESQIAGEN Builds On Leading Position In Precision Medicine With Novel Solutions In OncologyBy Business WireMay 28, 2020 4:05 PM EDT
PRESS RELEASESQIAGEN Announces Publication Of Reasoned Position Statement For Proposed Acquisition By Thermo Fisher And Date For Annual General MeetingBy Business WireMay 18, 2020 3:18 AM EDT
PRESS RELEASESQIAGEN Reports Full Results For First Quarter Of 2020By Business WireMay 6, 2020 4:05 PM EDT
PRESS RELEASESQIAGEN Expects Higher Results For Q2 2020 Based On Trends To Date And Suspends Outlook For Full-Year 2020By Business WireMay 5, 2020 4:55 PM EDT
PRESS RELEASESQIAGEN Posts IFRS Annual Report For 2019 Results And 2019 Annual Report On Its WebsiteBy Business WireApr 30, 2020 9:00 AM EDT
PRESS RELEASESQIAGEN N.V. To Report First Quarter 2020 ResultsBy Business WireApr 23, 2020 7:52 AM EDT
PRESS RELEASESSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates The Sale Of These Companies; Are Shareholders Getting A Fair Deal?By PR NewswireApr 20, 2020 10:57 PM EDT
PRESS RELEASESQIAGEN Launches Therascreen BRAF Test As Companion Diagnostic To A BRAFTOVI® (encorafenib) Based Regimen In Metastatic Colorectal CancerBy Business WireApr 15, 2020 4:05 PM EDT
PRESS RELEASESQIAGEN Receives U.S. FDA EUA For QIAstat-Dx Test Kit, First And Only Syndromic Solution Integrating Detection Of SARS-CoV-2 CoronavirusBy Business WireMar 31, 2020 4:05 AM EDT
PRESS RELEASESROSEN, A HIGHLY RANKED FIRM, Continues To Investigate Securities Claims Against QIAGEN N.V.By Business WireMar 26, 2020 3:30 PM EDT
PRESS RELEASESQIAGEN Names Thierry Bernard As Chief Executive OfficerBy Business WireMar 24, 2020 1:00 PM EDT
PRESS RELEASESQIAGEN Releases QIAstat-Dx Test Kit To The U.S. As First Syndromic Test For Detection Of SARS-CoV-2 Coronavirus Under New FDA PolicyBy Business WireMar 24, 2020 5:30 AM EDT
PRESS RELEASESQIAGEN Launches QIAstat-Dx Test Kit For Detection Of SARS-CoV-2 Coronavirus In Europe Following CE MarkingBy Business WireMar 18, 2020 7:00 PM EDT
PRESS RELEASESQIAGEN Dramatically Ramping Up Global Production Capacity For RNA Extraction Kits For Use In Detection Of SARS-CoV-2 CoronavirusBy Business WireMar 17, 2020 4:09 PM EDT
PRESS RELEASESINVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Qiagen N.V. And Encourages Investors With Losses In Excess Of $100,000 To Contact The FirmBy Business WireMar 16, 2020 12:19 PM EDT
PRESS RELEASESQIAGEN Gains BARDA Funding For Approval Process Of QIAstat-Dx Test Kit For SARS-CoV-2 CoronavirusBy Business WireMar 13, 2020 9:01 AM EDT
PRESS RELEASESSHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of QIAGEN N.V. - QGENBy PR NewswireMar 9, 2020 1:34 PM EDT
PRESS RELEASESMoore Kuehn Encourages Investors Of TIVO, MEET, QGEN, And GCAP To Contact Law FirmBy PR NewswireMar 5, 2020 2:15 PM EST
MARKETSStocks End Down After Wall Street Worries Rate Cut Won't Be EnoughBy Joseph WoelfelMar 3, 2020 4:14 PM EST
